Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma

Bajor et al.
Cancer Immunology Research
Papers
November 2014
Authors and Affiliates
Bajor DL1, Xu X2, Torigian DA3, Mick R4, Garcia LR5, Richman LP5, Desmarais C6, Nathanson KL7, Schuchter LM1, Kalos M2, Vonderheide RH8 1Abramson Cancer Center, University of Pennsylvania, Philadelphia. Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 2Abramson Cancer Center, University of Pennsylvania, Philadelphia. Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 3Abramson Cancer Center, University of Pennsylvania, Philadelphia. Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 4Abramson Cancer Center, University of Pennsylvania, Philadelphia. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 5Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, 6Adaptive Biotechnologies, Seattle, Washington, 7Abramson Cancer Center, University of Pennsylvania, Philadelphia. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 8Abramson Cancer Center, University of Pennsylvania, Philadelphia. Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia. rhv@exchange.upenn.edu.